OKO. V. Kraidashenko

O. V. Kraidashenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O. V. Kraidashenko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Panel of serum biomarkers for non-invasive assessment of glomerular and tubular injury in patients with chronic glomerulonephritis with and without arterial hypertension

    by O. V. Kraidashenko, M. O. Dolinna, Yu. M. Kolesnyk, O. O. Kremzer, O. O. Kraidashenko

    Aim: to analyze histological kidney features in patients with chronic glomerulonephritis (CGN) with and without arterial hypertension (AH) and to assess the relationship between serum cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and interleukin-18 (IL-18) levels and histological signs of glomerular and tubulointerstitial kidney injury in patients with preserved renal function. Material and methods. This observational study included 219 patients with biopsy-proven CGN and preserved renal function. Patients were stratified into two groups: CGN with AH (n = 149) and CGN without AH (n = 70). A control group consisted of 60 apparently healthy individuals. Serum levels of cystatin C, NGAL, and IL-18 were measured using enzyme-linked immunosorbent assay. Renal biopsy specimens were evaluated using standard semi-quantitative criteria. Statistical analyses included group comparisons, Spearman’s rank correlation and receiver operating characteristic curve analysis. Results. Patients with CGN and AH demonstrated significantly higher serum levels of IL-18, cystatin C, and NGAL compared with patients without AH and controls (p < 0.05). Median IL-18 levels were highest in the CGN with AH group, followed by the CGN without AH group and controls. Similar patterns were observed for cystatin C and NGAL. Serum cystatin C levels correlated with histological markers of glomerular injury, whereas NGAL and IL-18 were associated with tubulointerstitial damage. Biomarker elevations were more pronounced in patients with concomitant AH. Conclusions. A serum multimarker approach combining cystatin C, NGAL, and IL-18 effectively reflects compartment-specific glomerular and tubulointerstitial kidney injury in patients with CGN and preserved renal function. Arterial hypertension significantly enhances biomarker expression and structural kidney damage, supporting the clinical value of multimarker strategies for non-invasive assessment of renal injury in CGN.

  • Open Access

    The human genome and the gut microbiome: molecular mechanisms of interaction in the context of the holobiont concept

    by O. O. Kremzer, O. V. Kraidashenko, O. O. Kraidashenko

    Over the last decade, scientific understanding of the human body has shifted from an anthropocentric model to the concept of the holobiont – an integrated ecological unit consisting of the host and its microbiome. The interaction between the human genome and microbiota is a key determinant of physiology, metabolism, and disease susceptibility, yet the mechanisms of this genetic control remain insufficiently systematized. Aim. To analyze current data on the influence of the host genome on the formation and control of gut microbiota composition and function, and to identify key genetic loci and molecular mechanisms of interaction within the “genome – microbiome” system. Materials and methods. A review of scientific literature was conducted using PubMed, Scopus, and Web of Science databases. Results from genome-wide association studies (GWAS), twin studies, and molecular genetic research were analyzed. Results. Host genetics represents a significant factor in shaping the microbial profile, with heritability estimates for specific taxa ranging 5–45 %. Two main mechanisms of genetic control are identified: immune sculpting (genes NOD2, IL23R) and metabolic gardening (genes LCT, FUT2, APOA5). Synergistic effects of defects in these systems significantly increase the risk of chronic inflammatory and metabolic diseases. The hologenome concept, which views the combined genome of the host and microbiome as a single unit of evolution, is described. Conclusions. The host genome actively shapes the microbial ecosystem through immunological and metabolic mechanisms. Understanding these interactions paves the way for personalized medicine based on a hologenomic approach, particularly for developing individualized microbiome correction strategies.

  • Open Access

    CLINICAL CHARACTERISTICS OF MYOFASCIAL PAIN SYNDROME IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS

    by Evhenyi Mykhaliuk, Roman Kulynych, Oleh Kraidashenko

    Background. Chronic back pain is one of the most prevalent pain syndromes in the adult population and a major contributor to socioeconomic burden, with current evidence indicating that its leading cause is nonspecific musculoskeletal dysfunction, particularly myofascial syndrome, whose development is driven by complex peripheral and central neuromuscular mechanisms and often does not correlate with the severity of structural spinal changes detected by neuroimaging. Aim: to analyze the clinical characteristics of myofascial syndrome in patients with anxiety-depressive disorders and to assess the impact of mental health disorders on the development of chronic pain syndrome. Participants and methods. The study involved 46 people suffering from subacute or chronic back pain syndrome. The average age of patients was 42.1±3.5 years. The majority of the group was formed by women (n=37, 80.4%). The examination revealed that 22 (47.8%) patients had lumbalgia, 10 (21.7%) had cervicalgia, 6 (13.1%) had thoracalgia, and 8 (17.4%) patients had diffuse back pain or pain manifestations in multiple primary loci. The diagnostic complex included: neurological examination, neuroimaging methods, in particular magnetic resonance imaging (MRI) and/or computed tomography (CT) of the spine; as well as psychometric assessment of anxiety and depression levels using the Hospital Anxiety and Depression Scale (HADS), assessment of quantitative parameters and qualitative characteristics of pain using the SPAASMS short pain assessment questionnaire and the McGill Pain Questionnaire (MPQ), as well as assessment of cognitive and emotional perceptions of the disease and its impact on quality of life using the Brief Illness Perception Questionnaire (B-IPQ) Results. The study showed that chronic myofascial syndrome often coexisted with anxiety-depressive disorders. These psychoemotional disorders were significantly more common in patients with pain in the cervical and cervicothoracic regions, as well as in cases of fibromyalgia. An important feature of this group of patients was the detection of minimal neurological symptoms during objective examination and the absence of radiological signs of compression of neural structures according to MRI and CT data, despite the presence of significant pain on a subjective level, which affected the quality of life of patients. Combined treatment methods using meloxicam, B vitamins, chondroprotective drugs, physiotherapy, and psychotherapeutic interventions showed clinical efficacy in this cohort of patients. Conclusion. Management of patients with myofascial syndrome should include mandatory assessment of mental status and psychoemotional disturbances as factors contributing to pain chronicity; integration of these data into the therapeutic strategy ensures a comprehensive rehabilitation approach combining pharmacological treatment (anti-inflammatory and chondroprotective agents), physical and manual therapy, and psychotherapeutic interventions aimed at correcting emotional disorders.

  • Open Access

    Pathogenetic role of apoptosis biomarker expression in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension: a literature review

    by O. V. Kraidashenko, O. S. Tiahla, R. L. Kulynych, O. O. Soloviuk, V. V. Yakymenko, M. O. Panasenko

    It is well known that chronic obstructive pulmonary disease (COPD) and arterial hypertension (AH) are multifactorial diseases that develop as a result of complex interactions between genetic and environmental factors. Both internal and external factors can cause the activation of apoptosis, which is considered to be the key factor in the accelerated degradation and death of cells, leading to structural and functional disorders in organs. Apoptosis processes are initiated in the cells of affected organs long before the clinical manifestations of the disease become noticeable. Research and study of the triggering factors and pathobiology of apoptosis in AH and COPD can help to optimise screening programmes for the detection of these diseases in the early preclinical stages and develop new effective targeted treatment regimens based on blocking individual apoptosis pathways in cells. The aim of the study is to investigate the characteristics of the synthesis, metabolism and regulation of molecules, receptors and ligands involved in apoptosis in patients with COPD and AH. Materials and methods. For a systematic review of the literature, reviewed scientific articles indexed in leading scientometric databases (PubMed, Scopus, Google Scholar, and Web of Science) were used. Results. Apoptosis is a complex and multi-component process of programmed cell death. It has been proven that the processes of apoptosis in vascular endothelial cells, bronchial epithelial cells, and smooth muscle cells of the vascular and bronchial walls are significantly accelerated and scaled up in conditions of comorbid COPD and AH. Various molecules, ligands, and receptors are involved in the cascade of apoptotic changes, namely caspases 3, 7, 8, and 9, active forms of oxygen, calcium-dependent proteases, cytochrome C, parkin-4, Bcl-2 family proteins, apoptosis-related protein activator factor 1 (APAF-1), heat shock proteins, tumour necrosis factor, Fas ligand, Bax and p53 proteins, and soluble messenger proteins such as MFG-E8. Conclusions. There is a correlation between the dynamics of markers of apoptotic processes on the one hand and the severity of respiratory and haemodynamic disorders in COPD comorbidity with AH on the other. A detailed study of the mechanisms of initiation and regulation of neutrophil apoptosis involving cysteine proteases and other markers of apoptosis in patients with comorbid COPD and AH is a promising area of current research. Such data may form the basis for the correction of therapeutic regimens and allow for the optimisation of treatment.


  • Open Access

    Intestinal microbiome: basics of diagnostics for maintaining health

    by O. O. Kremzer, O. V. Kraidashenko, M. M. Prots

    Aim. To examine the impact of the gut microbiome on human health, as well as modern methods of its diagnosis, determining the role of modern diagnostic tests as a tool for assessing the microbiota state and its importance in personalized medicine. Materials and methods. A literature search was conducted in scientometric databases, including PubMed, Scopus, Web of Science, and Google Scholar, using the keywords: gut microbiome, microbiota diagnostics, GA-map dysbiosis test, fecal microbiota. The analysis included over 30 sources from specialized scientific literature. Results. The article covers the role of gut microbiome diagnostics in maintaining human health by presenting a comprehensive analysis of modern diagnostic methods, their comparative advantages and disadvantages, with a focus on the GA-map dysbiosis test as an innovative standardized approach. The authors review the historical context, dating all the way back to the Hippocrates’ views, and trace the evolution of microbiome studies to modern technological advances. Particular attention is paid to key aspects of microbiome composition, including recent changes in the nomenclature of bacterial phyla and the issues of various diagnostic method standardization. The article discusses the stages of development and clinical validation of the GA-map diagnostic test, emphasizing its advantages in providing standardized and reproducible results. The clinical application and interpretation of the test results are analyzed, demonstrating the importance of the test for personalized medicine approaches. The study reinforces the importance of understanding the gut microbiota for disease prevention and treatment, suggesting that standardized diagnostic methods such as GA-map could significantly improve clinical outcomes. Conclusions. The importance of maintaining microbiota balance for disease prevention has been emphasized. The GA-map dysbiosis test has demonstrated high accuracy and reproducibility allowing physicians to develop individualized nutrition and treatment recommendations and making it a key tool in modern medicine aimed at a personalized therapeutic approach.


  • Open Access

    Pharmacogenetic testing: current state of the issue

    by O. V. Kraidashenko, O. O. Kremzer, T. O. Samura

    Aim. The purpose of this work is to emphasize the importance and practical benefits of pharmacogenetics in medicine, demonstrating how the integration of pharmacogenetics into clinical practice can improve treatment outcomes and enhance the safety of therapies. Pharmacogenetics is a rapidly developing branch of pharmacology that studies how genetic variation affects an individual’s response to drugs. By understanding these genetic differences, healthcare providers can tailor drug therapy to maximize efficacy and minimize adverse drug reactions. The field aims to move away from the traditional one-size-fits-all approach and instead personalize medical treatment based on a person’s genetic makeup. The ability to predict a person’s response to medication based on their genetic profile has profound implications. For example, pharmacogenetic testing can identify patients at risk for life-threatening adverse drug reactions, such as drug-induced liver injury. This proactive approach can prevent adverse events, improving patient safety and the overall quality of care. In addition, pharmacogenetics aids in the development of new drugs by identifying genetic markers associated with drug responses, optimizing the drug development process, and reducing the time and costs associated with bringing new drugs to market. Key advances in pharmacogenetics include the identification of genetic polymorphisms in enzymes, such as cytochrome P450, that affect drug metabolism, thereby influencing both safety and efficacy. Pharmacogenetic testing allows doctors to predict the best drug and dosage for a patient, improving treatment outcomes and reducing the risk of adverse drug events. Despite its potential, the integration of pharmacogenetics into clinical practice faces challenges, including a lack of reliable clinical evidence, inadequate physician education, and the need for a comprehensive health IT infrastructure to support the use of genetic data. Ethical and legal issues, such as patient privacy and the risk of genetic discrimination, also present significant obstacles. However, continued research, the development of genetic testing technologies, and interdisciplinary collaborations are paving the way for more widespread adoption of pharmacogenetics, which promises to significantly improve patient care and healthcare efficiency. Key resources such as PharmGKB, CPIC, and the NIH provide valuable information and guidance for clinicians, researchers, and students, helping bridge the gap between genetics research and clinical application. Conclusions. Pharmacogenetics represents a significant advancement in personalized medicine, offering the potential to tailor drug therapies to individual genetic profiles. Although the field has made substantial progress, challenges remain in the form of insufficient clinical evidence, implementation barriers, and ethical concerns. Continued research and collaboration among stakeholders are essential to fully realize the benefits of pharmacogenetic testing in clinical practice.


  • Open Access

    ОСОБЛИВОСТІ ФОРМУВАННЯ КЛІНІЧНОГО МИСЛЕННЯ В КОНТЕКСТІ ВИКОРИСТАННЯ ТЕХНОЛОГІЙ ДИСТАНЦІЙНОГО НАВЧАННЯ

    by О. О. Свинтозельський, О. В. Крайдашенко, О. А. Михайлик

    Формування клінічного мислення у магістрів фармації з використанням дистанційних форм навчання в освітньому процесі викликає потребу в методологічних змінах технологій навчання та організації самого освітнього процесу, що формує нові виклики в педагогічній роботі. Мета роботи – визначити можливості використання дистанційних форм навчання при викладанні дисциплін «Фармакотерапія з основами фармакокінетики» і «Клінічна фармація та фармацевтична опіка» при формуванні клінічного мислення у студентів 4 та 5 курсів фармацевтичних факультетів і розробити можливі шляхи їх удосконалення. Матеріал для дослідження – досвід організації та проведення навчального процесу студентів, магістрів фармації ЗДМФУ з використанням дистанційних та змішаних форм навчання за останні 3 роки, звітна й інша облікова документація, анкетування студентів. Під час роботи використали методи контент-аналізу, наративного синтезу, групування, логіки та узагальнення. Підготовка майбутніх фахівців фармацевтичної галузі в Запорізькому державному медико-фармацевтичному університеті відбувається за дистанційною формою з використанням сучасних інформаційно-комунікаційних технологій та on-line сервісів, таких, як Office 365: MS Teams, MS Forms, MS SharePoint; Skype, Zoom, Ратос та EdX. У ЗДМФУ створені всі необхідні умови для реалізації інтернет-технологій навчання, що дозволяє студентам, успішно використовуючи інтерактивні методи, оволодіти всіма необхідними компетентностями відповідно до Освітньо-професійної програми. Моделювання різних компонентів та форм завдань, наближених до практичної роботи майбутнього фармацевта, у свою чергу, сприяє формуванню основ клінічного мислення у студентів старших курсів фармацевтичних факультетів. На нашу думку, використання в безперервному процесі освіти дистанційних технологій навчання за допомогою комп’ютерних навчальних on-line сервісів, таких, як Office 365: MS Teams, MS Forms, MS SharePoint; Skype, Zoom, Ратос та EdX, повинно отримати свою роль в удосконаленні навчального процесу, а саме: подання лекційного матеріалу повинно відбуватися в режимі реального часу, у вигляді відеоконференції, з використанням платформ MS Teams, Skype або Zoom, та можливістю попереднього доступу студентів до лекційного матеріалу, моделювання клінічних ситуацій для самостійної роботи з використанням on-line сервісів Office 365: MS Teams, MS Forms, Ратос сприяє оволодінню майбутніми магістрами фармації професійними навичками із формуванням клінічного мислення; впровадження та використання платформи «Інтерактивний пацієнт» (Body interactтм), або створення подібної спеціалізованої платформи, в умовах відсутності безпосереднього спілкування студент – хворий, є перспективним у формуванні клінічного мислення у студентів фармацевтичних факультетів та потребує подальшого вдосконалення у впровадженні в навчальний процес.